NYSE · ZEPP

Zepp Health Corporation American , each representing sixteen

$4.90 -$0.11 (-2.20%) 1D Market open

Key Metrics

$73.47M
Market cap
P/E · TTM
Revenue · TTM
Net income
EPS · TTM
Dividend yield
Free cash flow −$26.21M
Beta · 1Y 2.69
EBITDA · TTM
Gross margin

The Story So Far

LAST 6 MONTHS PRIMARY SOURCES ONLY
  • Jul 16
    Money rotated out of high-beta cohorts market-wide.

    High-beta names lagged the blue-chips by 18.6 points over ten sessions around this date. Stocks in that cohort weren't falling alone — they fell together.

    RECEIPT: ROTATION GAUGE, LIVE
  • Jun 10
    From its Feb 12 high, the share price fell 84%.

    Peak close $24.33 on Feb 12; trough close $3.99 on Jun 10. The drawdown is the fact — the chapters around it are the context.

    RECEIPT: PRICE SERIES, PEAK-TO-TROUGH -84%
  • Jun 9
    The stock moved -28.6% in a single session.

    Sessions this size usually pair with a chapter above or below — a filing, a headline, or the whole cohort moving together.

    RECEIPT: DAILY BAR, Jun 9
  • Feb 9
    The stock moved +26.8% in a single session.

    Sessions this size usually pair with a chapter above or below — a filing, a headline, or the whole cohort moving together.

    RECEIPT: DAILY BAR, Feb 9

The story updates itself as events post · The wolf reports; you decide

Snapshot

Market cap$73.47M
Enterprise value−$145.14M
Shares outstanding14.7M
52-wk range$3.85 – $61.85
Avg volume · 20D85.2K
Net cash $218.62M
Book value / share$14.63
ExchangeNYSE
About Zepp Health Corporation American , each representing sixteen
IPO dateFeb 8, 2018
Employees763

Zepp Health Corp is engaged in the business of manufacturing smart health wearable products. The company operates in one segment which is Amazfit-branded products. The product portfolio includes smartwatches and fitness bands.

Wolf Grade COMING SOON

The wolf is in training. Composite grades vs sector — profitability, health, value, momentum — arrive with the percentile engine. Methodology will be public.

Valuation

P/E
P/S
P/FCF
EV/EBITDA
EV/Sales
Graham №

Profitability

Gross
Operating
Net
FCF
ROE / ROIC — · —

Financial Health

Current ratio1.02
Quick ratio0.77
Debt / equity0.28
Debt / EBITDA
Net cash $218.62M
Working capital$6.68M

Cash Flow · TTM

Operating CF −$25.69M
Capex −$516.00K
Free cash flow −$26.21M
Buybacks $1.24M
Dividends paid
Shareholder yield 1.7%

Piotroski F-Score

4 / 9
Middling fundamentals · 4 of 9 signals passing

Altman Z-Score

Insufficient balance-sheet inputs

Graham Number vs Price

Requires positive earnings and book value
Fundamentals through 2025-12-31 · computed by TickerWolf from SEC filings